الأرستقراطي
عضو نشط
السهم استثمار قصير الى متوسط
theflyonthewall.com: PharmAthene upgraded to Outperform from Market Perform at Rodman & Renshaw
Rodman & Renshaw said the Final Judgement in PharmAtherne's (PIP) case vs. SIGA Tech (SIGA) had favorable economics and that PhamAtherne could collect over $1B in royalties. Price target is $7. :theflyonthewall
theflyonthewall.com: PharmAthene upgraded to Outperform from Market Perform at Rodman & Renshaw
Rodman & Renshaw said the Final Judgement in PharmAtherne's (PIP) case vs. SIGA Tech (SIGA) had favorable economics and that PhamAtherne could collect over $1B in royalties. Price target is $7. :theflyonthewall